Premium Subscribers: Complete your KYC to Avoid
Service Suspension. Login Here.

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Indoco Remedies Plunges 4%; BSE HEALTHCARE Index Down 0.2%
Wed, 28 Jan 10:12

Indoco Remedies Plunges 4%; BSE HEALTHCARE Index Down 0.2%Image source: Chunumunu/www.istockphoto.com

Indoco Remedies share price has plunged 4% and is presently trading at Rs 210.9.

Meanwhile, the BSE HEALTHCARE index is at 41,182.2 (down 0.2%).

Among the top losers in the BSE HEALTHCARE index today are MAX HEALTHCARE INSTITUTE (down 1.7%) and KIMS (down 1.3%).

NARAYANA HRUDAYALAYA (up 2.6%) and Pfizer (up 1.3%) are among the top gainers today.

Over the last one year, Indoco Remedies has moved down from Rs 288.4 to Rs 210.9, registering a loss of Rs 77.6 (down 26.9%).

On the other hand, the BSE HEALTHCARE index has moved down from 43,143.6 to 41,182.2, registering a loss of 4.5% during the last 12 months.

The top losers among the BSE HEALTHCARE index stocks during this same period were COHANCE LIFESCIENCES (down 64.0%), SYNGENE INTERNATIONAL (down 43.0%) and Natco Pharma (down 37.5%).

Live Now: The Small Cap Proxy Players Briefing

What About the Benchmark Indices?

The BSE Sensex is at 82,250.6 (up 0.5%).

The top gainers among the BSE Sensex today are Axis Bank (up 2.1%) and Eternal Ltd (up 1.4%). The most traded stocks in the BSE Sensex are Bajaj Finserv and Eternal Ltd.

In the meantime, NSE Nifty is at 25,252.1 (up 0.3%). ONGC and Coal India are among the top gainers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved up from 76,520.4 to 82,250.6, registering a gain of 5,730.2 points (up 7.5%).

Indoco Remedies Financial Update...

Indoco Remedies net profit grew 8.0% YoY to Rs -92 million for the quarter ended September 2025, compared to a loss of Rs 100 million a year ago. Net sales rose 12.0% to Rs 4,847 million during the period as against Rs 4,327 million in July-September 2024.

For the year ended March 2025, Indoco Remedies reported 180.4% decrease in net profit to Rs -780 million compared to net profit of Rs 970 million during FY24. Revenue of the company fell 8.4% to Rs 16,649 million during FY25.

The current Price to earnings ratio of Indoco Remedies, based on rolling 12 month earnings, stands at -16.9.


Equitymaster requests your view! Post a comment on "Indoco Remedies Plunges 4%; BSE HEALTHCARE Index Down 0.2%". Click here!